In this article by Messerli et al.[1], table 2 was incorrectly published. The correct table 2 is shown below:
TABLE 2.
Beta-blockers | RAS blockers | Calcium-channel blockers | Thiazides | Renal denervation | |
BP decrease, sustainability | years, decades | years, decades | years, decades | years, decades | months |
BP paradox responders | yes | ? | no | no | yes |
BP variability | ? | ? | ↓↓↓ | ↓↓ | ↓ |
BP decrease age dependent | yes | yes | no | no | yes |
Heart rate | ↓↓ | no | no | no | ↓ |
Plasma renin activity | ↓↓ | ↑↑↑ | ?↑ | ↑↑ | ↓↓ |
Sympathetic activity | ↓↓ | ↓ | no | ↑ | ↓↓ |
Morbidity and mortality | inconsistent evidence | ↓↓ | ↓↓ | ↓↓↓ | no evidence |
REFERENCE
- 1.Messerli FH, Bavishi C, Brguljan J, Burnier M, Dobner S, et al. Renal denervation in the antihypertensive arsenal - knowns and known unknowns. J Hypertens 2022; 40:1859–1875. [DOI] [PMC free article] [PubMed] [Google Scholar]